Of note were the complete tumor regressions observed in the YUMM1.7 model, a more clinically relevant murine model that harbors important molecular aberrations observed in human melanoma (including in Braf V600E, and inactivated Cdkn2a and Pten) (39). This evidence concerns the gene PTEN and neoplasm.